Federated Hermes’s Arcturus Therapeutics ARCT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.1M | Hold |
4,694,060
| – | – | 0.12% | 222 |
|
|
2025
Q1 | $49.7M | Hold |
4,694,060
| – | – | 0.11% | 237 |
|
|
2024
Q4 | $79.7M | Hold |
4,694,060
| – | – | 0.17% | 155 |
|
|
2024
Q3 | $109M | Hold |
4,694,060
| – | – | 0.24% | 102 |
|
|
2024
Q2 | $114M | Sell |
4,694,060
-1,312
| -0% | -$31.9K | 0.27% | 85 |
|
|
2024
Q1 | $159M | Sell |
4,695,372
-16,140
| -0.3% | -$545K | 0.37% | 54 |
|
|
2023
Q4 | $149M | Hold |
4,711,512
| – | – | 0.37% | 57 |
|
|
2023
Q3 | $120M | Sell |
4,711,512
-66,988
| -1% | -$1.71M | 0.32% | 67 |
|
|
2023
Q2 | $137M | Hold |
4,778,500
| – | – | 0.34% | 58 |
|
|
2023
Q1 | $115M | Buy |
4,778,500
+538,946
| +13% | +$12.9M | 0.29% | 70 |
|
|
2022
Q4 | $71.9M | Buy |
4,239,554
+672,057
| +19% | +$11.4M | 0.2% | 115 |
|
|
2022
Q3 | $52.9M | Buy |
3,567,497
+6,400
| +0.2% | +$94.8K | 0.15% | 175 |
|
|
2022
Q2 | $56.1M | Sell |
3,561,097
-200,803
| -5% | -$3.16M | 0.15% | 178 |
|
|
2022
Q1 | $101M | Buy |
3,761,900
+66,971
| +2% | +$1.81M | 0.23% | 116 |
|
|
2021
Q4 | $137M | Buy |
3,694,929
+649,641
| +21% | +$24M | 0.25% | 102 |
|
|
2021
Q3 | $146M | Buy |
3,045,288
+17,288
| +0.6% | +$826K | 0.28% | 96 |
|
|
2021
Q2 | $102M | Sell |
3,028,000
-175,000
| -5% | -$5.92M | 0.19% | 148 |
|
|
2021
Q1 | $132M | Sell |
3,203,000
-249,810
| -7% | -$10.3M | 0.26% | 94 |
|
|
2020
Q4 | $150M | Buy |
3,452,810
+2,076,135
| +151% | +$90.1M | 0.31% | 78 |
|
|
2020
Q3 | $59.1M | Buy |
1,376,675
+761,631
| +124% | +$32.7M | 0.14% | 173 |
|
|
2020
Q2 | $28.7M | Buy |
+615,044
| New | +$28.7M | 0.07% | 310 |
|